Mozart Therapeutics
Mozart Therapeutics is a biotech company based in Seattle, Washington that develops therapies targeting celiac disease and...
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology, Therapeutics
- Founded
- 2023
- Type
- Corporation Seattle business license
- Registered name
- Mozart Therapeutics Inc Seattle business license
Mozart Therapeutics Raises $25M to Advance Autoimmune Disease Drug MTX-101 with FDA IND Planned for Early 2024
Seattle biotech Mozart Therapeutics secured $25 million to advance MTX-101, its drug candidate for autoimmune gastrointestinal diseases, aiming for FDA IND submission by early 2024. The company, led by CEO Katie Fanning and supported by notable investors, has raised a total of $80 million since its 2020 launch.
